Image: NBC NewsMerck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma
• Merck and Moderna announced that an experimental cancer vaccine-drug combination shows promise in preventing the recurrence of melanoma in high-risk patients. • While full trial data has not yet been published, previous research presented in June at the American Society of Clinical Oncology meeting indicated the treatment halved the risk of recurrence over five years for 157 patients. • This development is significant as it suggests a potential breakthrough in long-term cancer survival and the prevention of relapse for high-risk individuals.
nbcnews.com